Wei Li

This publication record, listed under the name Wei Li, spans a very wide range of topics including CRISPR gene-editing technology, single-cell genomics, cancer immunology, plant genomics, and even unrelated fields like international relations, suggesting the name aggregates work from multiple distinct researchers rather than one coherent research program. Within the biology-focused subset, common themes include gene-editing tools (CRISPR-Cas systems), single-cell and multi-omics analysis methods, and applications in cancer, immune cells, and microbial engineering. Because the data likely reflects several different authors sharing this name, prospective students should treat any specific research focus described here with caution and verify authorship directly with the institution.

Publication counts fluctuated over the past decade, rising to a peak around 2020 and 2023 before declining notably in 2024-2026, though this pattern may reflect multiple co-mingled author identities rather than one individual's trajectory.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026